+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

MANPEI SUZUKI INTERNATIONAL PRIZE FOR DIABETES RESEARCH

MANPEI SUZUKI DIABETES FOUNDATION

The Manpei Suzuki International Prize is for original and excellent achievements in diabetes research. By providing this opportunity to researchers of the world, we hope to advance diabetes research that will contribute to the health and welfare of all people.

News

01 Apr 2026		Nominations open for 2026 Manpei Suzuki International Prize for Diabetes Research Nomination Open April 1st to July 1st, 2026
05 Mar 2026		2025 Award Ceremony has been held on March 4th, 2026
01 Dec 2025		2025　Winner of the Manpei Suzuki International Prize for Diabetes Research　:　 Roman Hovorka, PhD.
01 Jul 2025		Nominations close for 2025 Manpei Suzuki International Prize for Diabetes Research

Sponsor

Manpei Suzuki Diabetes Foundation, Tokyo, Japan

Scope of Nomination Application

Nominations in English can be accepted from any country. One prize winner will be selected from nominations received in that year. For subsequent years, a re-submission will be required for consideration in that year.

Scope of Nominator

Members of ADA, EASD, JDS or other publicly recognized societies of related fields can submit one nomination application per person per year.
Each nomination application will require one supporting letter from someone who is familiar with the work of the nominee and who is also a member of the above-said societies. Self nomination is not acceptable.
A nominator can not be a supporter for any nominees.

Scope of Nominee

The prize will be awarded to one researcher in diabetes who has been nominated as described above. Previous prize awards are not considered.
However, any of a member of the Selection Committee of this Prize shall not be eligible for a nominee.

Awarding of Prize

Certificate of Honor, US$200,000 prize and Japanese objet d'art to one individual.

Selection

1. The Selection Committee reviews all applications and decides on the prize recipient.
2. The prize recipient and nominator are notified.
3. A public announcement is made.

AI Based Application Success Predictor

1. Strong focus on diabetes and metabolic disease research (highest predictor)

This is the most important predictor.

Funded projects are expected to have clear relevance to:

Type 1 diabetes
Type 2 diabetes
Diabetic complications
Diabetes prevention
Insulin resistance
Obesity-related metabolic disorders
Diabetic kidney disease
Diabetes pathophysiology
Novel diabetes therapeutics

Projects with direct implications for improving diabetes care or understanding disease mechanisms are most competitive.

2. Scientific excellence and originality (very high predictor)

The Foundation supports research that advances the field through:

Novel hypotheses
Innovative methodologies
Mechanistic insights
New therapeutic targets
Emerging technologies

Awardees and grant recipients frequently conduct cutting-edge diabetes research rather than incremental studies.

3. Strong early-career investigator potential (very high predictor)

A distinctive feature of the Foundation is its dedicated Young Researcher Research Grant program.

Reviewers favor applicants who demonstrate:

Research independence potential
Clear academic career trajectory
Long-term commitment to diabetes research
Emerging leadership in diabetology

The Foundation explicitly operates programs designed to foster future diabetes investigators.

4. Strong publication record and prior productivity

Successful applicants typically demonstrate:

Peer-reviewed publications
Conference presentations
Prior diabetes-related research
Evidence of scholarly productivity

Even among young investigators, a track record of research output substantially strengthens competitiveness.

5. Potential to improve understanding or treatment of diabetes

Projects that may lead to:

Better prevention strategies
Earlier diagnosis
Novel biomarkers
Improved therapies
Reduced diabetic complications
Precision medicine approaches

align particularly well with the Foundation's mission.

6. Strong institutional support and mentorship

Several grant mechanisms require formal recommendations from:

Professors
Research supervisors
Department leaders
Institutional directors

This indicates that institutional endorsement and a supportive research environment are important review considerations.

7. Feasible and well-designed research plan

Competitive applications generally include:

Clear aims
Robust methodology
Appropriate statistical plans
Realistic timelines
Achievable milestones

The Foundation funds projects ranging from approximately ¥1 million to ¥8.5 million, making feasibility an important criterion.

8. International collaboration and research development potential

Through Overseas Study Grants, Foreign Researcher Invitation Grants, and international activities, the Foundation encourages:

International collaboration
Research exchange
Global diabetes research networks
Technology and knowledge transfer

Projects that create long-term collaborative opportunities may have an advantage.

9. Potential for future larger-scale funding

Many Foundation awards function as seed funding.

Competitive projects often:

Generate preliminary data
Establish new research directions
Lead to national grants
Support future AMED, JSPS, NIH, or international funding applications

Reviewers are likely to favor projects that can grow into sustained research programs.

Specialties

Endocrinology and Diabetes

Eligibility Requirements

Sponsor Details

Sponsor Institute/Organizations: MANPEI SUZUKI DIABETES FOUNDATION

Sponsor Type: Corporate/Non-Profit

Address: Manpei Suzuki Diabetes Foundation 3-14-10, Nihonbashi Chuo-ku, Tokyo 103-8234,Tel : +81 80-4750-2655

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity